ARTICLE | Clinical News
Crofelemer: Phase IIb started
November 6, 2006 8:00 AM UTC
Trine began a double-blind, placebo-controlled, U.S. Phase IIb trial in about 240 women. The trial start triggered a $1 million milestone payment to NAPL, which granted Trine worldwide rights to Crofe...